These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24419975)

  • 1. Role of the C-terminal region of vervet monkey polyomavirus 1 VP1 in virion formation.
    Yamaguchi H; Kobayashi S; Maruyama J; Sasaki M; Takada A; Kimura T; Sawa H; Orba Y
    J Vet Med Sci; 2014 May; 76(5):637-44. PubMed ID: 24419975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.
    Voronkova T; Kazaks A; Ose V; Ozel M; Scherneck S; Pumpens P; Ulrich R
    Virus Genes; 2007 Jun; 34(3):303-14. PubMed ID: 16927120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.
    Norkiene M; Stonyte J; Ziogiene D; Mazeike E; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2015 Aug; 15():68. PubMed ID: 26239840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of recombinant trichodysplasia spinulosa-associated polyomavirus VP1-derived virus-like particles using chromatographic techniques.
    Zaveckas M; Goda K; Ziogiene D; Gedvilaite A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1090():7-13. PubMed ID: 29778875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity.
    Gedvilaite A; Aleksaite E; Staniulis J; Ulrich R; Sasnauskas K
    Arch Virol; 2006 Sep; 151(9):1811-25. PubMed ID: 16575481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VP1, the major capsid protein of the mouse polyomavirus, binds microtubules, promotes their acetylation and blocks the host cell cycle.
    Horníková L; Fraiberk M; Man P; Janovec V; Forstová J
    FEBS J; 2017 Jan; 284(2):301-323. PubMed ID: 27885808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the carboxyl-terminal region of the SV40 major capsid protein VP1.
    Yokoyama N; Kawano MA; Tsukamoto H; Enomoto T; Inoue T; Takahashi RU; Nakanishi A; Imai T; Wada T; Handa H
    J Biochem; 2007 Feb; 141(2):279-86. PubMed ID: 17283011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
    Gedvilaite A; Dorn DC; Sasnauskas K; Pecher G; Bulavaite A; Lawatscheck R; Staniulis J; Dalianis T; Ramqvist T; Schönrich G; Raftery MJ; Ulrich R
    Virology; 2006 Oct; 354(2):252-60. PubMed ID: 16904154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity against both polyomavirus VP1 and a transgene product induced following intranasal delivery of VP1 pseudocapsid-DNA complexes.
    Clark B; Caparrós-Wanderley W; Musselwhite G; Kotecha M; Griffin BE
    J Gen Virol; 2001 Nov; 82(Pt 11):2791-2797. PubMed ID: 11602791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear entry mechanism of the human polyomavirus JC virus-like particle: role of importins and the nuclear pore complex.
    Qu Q; Sawa H; Suzuki T; Semba S; Henmi C; Okada Y; Tsuda M; Tanaka S; Atwood WJ; Nagashima K
    J Biol Chem; 2004 Jun; 279(26):27735-42. PubMed ID: 15069063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.
    Sasnauskas K; Bulavaite A; Hale A; Jin L; Knowles WA; Gedvilaite A; Dargeviciūte A; Bartkeviciūte D; Zvirbliene A; Staniulis J; Brown DW; Ulrich R
    Intervirology; 2002; 45(4-6):308-17. PubMed ID: 12602348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs.
    Tegerstedt K; Andreasson K; Vlastos A; Hedlund KO; Dalianis T; Ramqvist T
    J Gen Virol; 2003 Dec; 84(Pt 12):3443-3452. PubMed ID: 14645925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutation in calcium-binding domain of mouse polyomavirus VP1 protein does not prevent virus-like particle formation, but changes VP1 interactions with Saccharomyces cerevisiae cell structures.
    Adamec T; Palková Z; Velková K; Stokrová J; Forstová J
    FEMS Yeast Res; 2005 Feb; 5(4-5):331-40. PubMed ID: 15691738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
    Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
    Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization of avian polyomavirus structural protein VP1 is a prerequisite for the formation of virus-like particles.
    Johne R; Müller H
    J Virol; 2004 Jan; 78(2):930-7. PubMed ID: 14694124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast cells allow high-level expression and formation of polyomavirus-like particles.
    Sasnauskas K; Buzaite O; Vogel F; Jandrig B; Razanskas R; Staniulis J; Scherneck S; Krüger DH; Ulrich R
    Biol Chem; 1999 Mar; 380(3):381-6. PubMed ID: 10223341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles.
    Devant JM; Hofhaus G; Bhella D; Hansman GS
    Antiviral Res; 2019 Aug; 168():175-182. PubMed ID: 31145925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.